SNWV sanuwave.com Profit After Tax

Corporate emblem and logo of sanuwave.com (SNWV)

Sanuwave Health Inc (SNWV) develops devices for healing chronic skin injuries using proprietary sound waves. The company faces competition from traditional dressings and innovative bioregeneration methods. This chart reflects the stock price at 0.01. While electronics manufacturing is outsourced to third-party contractors, key acoustic research remains in-house, eliminating dependence on a single supplier.

Net Income: SANUWAVE Health, Inc. (SNWV) for 03/08/2025 - 11/01/2026

Financial and market metric breakdowns for SANUWAVE (SNWV)

- market value and analyst target forecast:
Stock Price SANUWAVE Health Inc|SNWV - Price Target Chart
- market capitalization data:
Market Valuation SANUWAVE Health Inc|SNWV - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share SANUWAVE|SNWV - Company Net Assets|Market Capitalization to Book Value Ratio sanuwave.com|SNWV - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital Sanuwave Health Inc|SNWV - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient SANUWAVE Health|SNWV - Company Aggregate Debts|Debt to Book Value SANUWAVE Health Inc|SNWV - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings SANUWAVE|Quick Liquidity Indicator sanuwave.com
- company profitability and valuation multiples indicators:
SNWV - Net Profit
Fundamental valuation:SNWV, SANUWAVE Health Inc
Flagship merchandise of SANUWAVE Health, Inc.

Sanuwave Health Inc (SNWV) specializes in developing non-invasive shockwave therapy systems for the treatment of diabetic ulcers. The company's profit level dynamics demonstrate the effectiveness of commercializing these medical technologies. This metric is calculated as daily net income, reflecting the real margins of the business under current monetary policy. The current value of 0.01 allows for an assessment of the operational flow's stability. Analyzing this trajectory helps balance the asset's potential yield against impairment risks.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|OM (outsetmedical.com) - Final Profit|Company Net Income Electromed ELMD|LNSR - Net Income|AVITA Medical, Inc - Net Profit|Company Net Income Profound Medical Corp.|BDMD: Net Profit|Company Profit EDAP|APYX (Apyx Medical Corp) - Net Profit|IceCure Medical, Ltd. (ICCM) - Net Financial Result|Net Profit LUNG|Net Income telabio.com TELA|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|reshapelifesciences.com (RSLS) - Company Net Income|SILK - Net Financial Result